Questions needed: "Ask Bill Roberts" column

What does he think of the risk/reward (or cost/benefit) ratio of the SARMS - Ostarine, S-4, LGD 50156, MK-6077?

Oversupplementing - taurine/creatine/DAA/Vitamin-D - where is the point of diminishing returns?

Using those "supplements" from the outset, IMO
 
Much like "enteric coated ASA" an ester ONLY effects the half life of an AAS compound. It should have essentially no impact on the efficacy of an anabolic agent providing equipotent doses of the parent compound are being compared.
That makes the most sense to me.

However I have heard firsthand account of contrary experiences. Imaginary? Hmm...
 
Back
Top